Endocrinology

We have carefully reviewed this court ruling, which addresses the consent of children and young people to the use of puberty suppressing drugs as part of the treatment of gender dysphoria. We consider that the ruling should not have implications for the general ethical or legal framework for childre...

We’ve made innovative adaptations to keep Paediatric diabetes on the radar during the COVID-19 pandemic to improve care and outcomes.

Dr Andrea Srur, Programme Manager for the national Diabetes Quality Programme, describes the recent successes from this project and the challenges presented by the COVID-19 outbreak.

We look ahead to plans for digital growth charts, which will be available to parents and carers in 2021.

The National Paediatric Diabetes Audit (NDPA) 2018/19 Annual Report on Care Processes and Outcomes was published today by the Royal College of Paediatrics and Child Health (RCPCH).

NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.